3D cell culture | HCS Pharma

Biomimesys

New 384-well plates format for BIOMIMESYS® Liver & Oncology entitling Cell-Based Assays High-Throughput Screening

HCS-Pharma is pleased to launch BIOMIMESYS® Liver and Oncology in ready-to-use 384-well plate format for screening applications. Adopt BIOMIMESYS® 3D cell culture systems and obtain more predictive in vitro models. You can find our presentations in PDF format for BIOMIMESYS® Liver https://www.hcs-pharma.biz/share/public/hcspharma-flyer-biomimesys-liverv0 for BIOMIMESYS® Oncology https://www.hcs-pharma.biz/share/public/hcspharma-flyer-biomimesys-oncologyv0 For more information, contact Read more…

By Grégory MAUBON, 1 week5 days ago

Our news

3D co-culture of dopaminergic neurons and astrocytes in BIOMIMESYS® Brain to study Parkinson’s disease

Parkinson’s disease affects more than 6 million people worldwide. This neurodegenerative disease is characterized by the death of dopaminergic neurons in the substantia nigra pars compacta, with intracellular accumulation of alpha-synuclein aggregates known as Lewi bodies. This neuronal loss leads to a decrease in the neurotransmitter dopamine that cause mainly Read more…

By Véronique De Conto, 3 weeks3 weeks ago

BioPharMEMS

Our involvement in preclinical breast cancer research

On the occasion of the breast cancer awareness month, HCS Pharma is willing to thank all researchers working in the field to better understand the pathophysiology of disease, with the objective to find more efficient anti-cancer therapies. We would like to warmly thank the researchers with whom we are collaborating Read more…

By Elodie Vandenhaute, 1 month5 days ago

Our news

Vaihere joins us as a lab technician

Vaihere Cheung obtained her technology A-level (STL) in 2018 at La Mennais, in French Polynesia. Then she came to metropolitan France to reach a technician diploma in Biological engineering, specialized in biological and biochemical analysis, at the University of Lyon. During her studies, Vaihere did an internship in HCS Pharma Read more…

By Véronique De Conto, 2 months5 days ago

HCS, HCA & Biology

Importance of CAF-ECM interplay in cancer

At the occasion of the Breast Cancer Awareness Month, we would like to highlight the role of the interplay between the extracellular environment and the Cancer-Associated Fibroblasts (CAFs) on the tumoral development, including breast cancers. In our previous articles, we described the pro-tumoral effect of the extracellular environment. Moreover, an Read more…

By Marie Lesaffre, 2 months5 days ago

Biomimesys

BIOMIMESYS® for assessing anti-cancer treatments

This summer, Vitali et al. published an article in the Open Access Journal Cancers in which they assessed anticancer combination to treat neuroendocrine tumors (NETs) using in vitro models (2D + 3D cultures in BIOMIMESYS hydroscaffolds). A NET arises in the specialized cells of the neuroendocrine system, which have traits of Read more…

By Elodie Vandenhaute, 2 months5 days ago

Our news

Back to work with a significant change for HCS Pharma: focus on in vitro 3D cell culture as close as possible to real human organs

You may have noticed on our website: we have changed our logo this summer, and it is the most visible part of our strategic development. Of course, we are always experts in HCS and cell imaging but, for us, it is the perfect time to show our deep expertise in Read more…

By Grégory MAUBON, 3 months3 months ago

Our news

Let’s talk about BIOMIMESYS® uses (by our partners)

As we are involved in some very interesting projects, we have the chance to work with amazing specialists in many field. All these people help us to make the BIOMIMESYS® technology better, easier to use and well adapted to their work. We asked them to explain why they use BIOMIMESYS® Read more…

By Grégory MAUBON, 6 months6 months ago

HCS, HCA & Biology

BIOMIMESYS hydroscaffold for your coronavirus-related research in 3D

Clinicians and researchers worldwide are actively studying the mechanisms governing the infection of humans by SARS-CoV-2 and its consequences on their health, with the objective is to find effective therapies. We all aknowledge their important role in the current crisis – and in preventing future ones! While respiratory symptoms are Read more…

By Elodie Vandenhaute, 8 months8 months ago

Our news

COVID-19 pandemic impacts HCS Pharma activities

As many companies in France and in the world, the COVID-19 pandemic deeply affects our activities. For safety reasons, most of our work is now done remotely but we maintain essential activity in laboratories to take care of our cells and try to finish our ongoing customer studies. The situation Read more…

By Grégory MAUBON, 9 months9 months ago

Our news

We will attend HCS User Meeting by Molecular Devices in Leiden next week

We will give a presentation next week (on Tuesday, 10th of March 2020) at the High-Content Cellular Imaging User meeting organized by our partner Molecular Devices, which will take place in Leiden (Netherlands). It is a great pleasure for us to attend the meeting, and to talk about the applications, Read more…

By Elodie Vandenhaute, 9 months5 days ago

Our news

We’ll be at BioFit next week (with a great offer)!

Nathalie and Elodie will be present in Marseille for BioFit event next week! Indeed, HCS Pharma has a booth in Clubster NSL’s pavilion (number I20). Just stop by 🙂 It will be a pleasure to talk to you about the innovative 3D cell culture matrix BIOMIMESYS® and our related services Read more…

By Elodie Vandenhaute, 1 year5 days ago

Our news

Great business trip in Taiwan thanks to Molecular Devices and Tokyo Future style, Inc.!

We were in Taiwan few weeks ago, invited by our partner Molecular Devices to talk about our skills in 3D cell culture, with our unique groundbreaking technology BIOMIMESYS® and our services for in vitro screening from cell assay development to picture and data analysis. It was also a perfect opportunity Read more…

By Grégory MAUBON, 1 year5 days ago

Our news

Feedback from NutrEvent 2019 in Rennes

Last week, our study director Elodie was in Rennes to participate in NutrEvent! We had a booth there, under NSL Clubster pavilion (Lille Northern France Health and Nutrition clubster). It was a pleasure for her to present our activities in imaging and our 3D cell culture products to the visitors! Read more…

By Elodie Vandenhaute, 1 year5 days ago

Our news

Come to see Elodie on stand D6 @ NutrEvent 2019!

Elodie is waiting for you on the first floor at Nutr’event 2019! HCS Pharma stand is n° D6/2, on Clubster NHL pavilion. She will be glad to discuss with you about: our in vitro tests for the objectivation of your claims on human cells (e.g. nutraceutical, dermocosmetic claims) our innovative Read more…

By Elodie Vandenhaute, 1 year5 days ago

Our news

Meet HCS Pharma @ Nutrevent in Rennes next week!

With more than 25 countries represented, NutrEvent is THE place to be for business and innovation in Food, Nutrition and Health. It will take place next week in Rennes congress centre (Couvent des Jacobins), on the 22nd and 22rd of October. Our stand will be on Eurasanté Pavilion (Level 1 Read more…

By Elodie Vandenhaute, 1 year5 days ago

Our news

Optimizing high-content screening tools for physiologically-relevant 3D in vitro models : The Webinar!

We are very happy to share with you about HCS and 3D in vitro models thanks to a labroots.com webinar on October 27, 2019! This webinar is made with our partner Molecular Devices and it will present you many tips on how to handle 3D cell culture systems such as Read more…

By Grégory MAUBON, 1 year1 year ago

Our news

Meet us at Termis workshop in Nantes next week to talk about BIOMIMESYS® and human-on-a-chip!

We will attend Termis workshop (August 26-27 in Nantes, France) to present our innovations on 3D cell culture and, of course, our brand new BIOMIMESYS® products! In our new poster, you will find how we used BIOMIMESYS® Liver hydroscaffold to create a liver-on-chip for mimicking the liver extracellular matrix. We Read more…

By Grégory MAUBON, 1 year5 days ago

HCS, HCA & Biology

Extracellular matrix (ECM) properties might predict breast cancer outcome

The extracellular matrix (ECM) is known as a molecular network of macromolecules present in all solid tissues (Figure 1), which plays an important role in the growth, migration and differentiation of cells. This ECM is part of a complex and plastic microenvironment in health and disease: its composition and physical Read more…

By Elodie Vandenhaute, 1 year5 days ago

HCS, HCA & Biology

SelectBio events on 3D culture and biochip systems last week : surprises and possibilities!

It was a great pleasure to be invited (thanks to our partner Molecular Devices) to present our work during these 2 events organized by selectBio in Rotterdam: Organoids and Tox Screening Europe 2019 on June 13-14 Organ-on-a-Chip and Tissue-on-a-Chip Europe 2019 on June 18-19 Both were of great interest for Read more…

By Grégory MAUBON, 1 year5 days ago

HCS, HCA & Biology

Hyaluronic Acid : structure – function relationship

In the continuity of our scientific reviews about the important roles of Hyaluronic Acid (HA) in extracellular matrix (ECM) and cell behavior, we herein present this recent review describing the structure – function relationship of HA. As an important polysaccharide of ECM, HA plays an important role in cell and Read more…

By Zied Souguir, 1 year1 year ago

Our news

Summary from the founding congress of STCM last week

Last week we were pleased to attend the founding congress of STCM (Société de Toxicologie Cellularie et Moléculaire), which was held in FIAP Jean Monnet (Paris). The topic was “Toxicology towards the 3rd dimension“. With a wide variety of talks from academic laboratories and from the industry, the content was Read more…

By Elodie Vandenhaute, 1 year5 days ago

Our news

Founding congress of STCM association in Paris this week

The founding congress of the french STCM (Société de Toxicologie Cellulaire et Moléculaire) will take place in Paris at the end of this week (13th-14th June, 2019). The theme of this meeting will be “Toxicology towards the 3rd dimension“. We are looking forward to attending this congress, and to becoming Read more…

By Elodie Vandenhaute, 1 year5 days ago